China strengthens nucleic acid testing

China strengthens nucleic acid testing
A man takes a test tube for COVID-19 nucleic acid testing in Zhangjiajie, central China's Hunan Province, Aug. 10, 2021. Since the recent resurgence of COVID-19 in Zhangjiajie from July 29, the city has reported 53 locally-transmitted confirmed cases, and three asymptomatic carriers are currently under medical observation. (Xinhua/Chen Sihan)

BEIJING, Aug. 10 (Xinhua) — Requirement and measures have been issued in China to strengthen nucleic acid testing amid a resurgence of COVID-19 in multiple localities.

All-inclusive testings on a population of 5 million or less should be completed in two days, and a three-day limit was set for populations of more than 5 million people, said a circular published by the State Council joint prevention and control mechanism against COVID-19.

Nucleic acid testing is a vital way to identify the infected and prevent the epidemic from spreading, the circular said.

No one should miss out on the testings while measures were needed to prevent cluster infection during testings, the circular demanded.

Drills on the testings were proposed for areas without the epidemic so that emergency response could be immediately activated when necessary.

XINHUA

Xinhua News Agency, founded on November 7, 1931, is China’s national news agency as well as a global news and information network. Xinhua has set up a global news and information gathering network, with headquarters in Beijing, 33 domestic bureaus in provinces, autonomous regions and municipalities plus the special administrative regions of Hong Kong and Macao, as well as 140 bureaus in the rest of the world. Xinhua is yet to set up a bureau in Taiwan, where it has posted resident correspondents. Xinhua provides its worldwide subscribers with news and financial information products in the forms of text, photo, graphics, audio, video, and mobile phone text messages 24 hours a day in eight languages: Chinese, English, French, Russian, Spanish, Arabic, Portuguese and Japanese.